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Effects of hyperosmolality on ANP-stimulated cGMP generation in rat
inner medullary collecting duct. The innner medullary collecting duct
(IMCD) is a major target site of atrial natriuretic peptide (ANP) for
diuresis and natriuresis, and it is in a hypertonic condition made by the
renal countercurrent multiplication system. We investigated the effects
of hyperosmolality on ANP-stimulated cGMP generation in IMCD and
glomerulus, Hypertonic solutions (490 and 690 mOsm/kg H20) were
made by adding NaCI or urea to isotonic solution (290 mOsm/
kg H20). Hypertonicity of 490 mOsm/kg H20 using NaCl reduced
both ANP-stimulated guanylate cyclase activity (from 7.7 1.1 to 4.1
0.5 fmollmm/5 mm) and cGMP generation (from 1.35 0.18 to 0.48
0.20 fmol/mm/3 mm) in IMCD. Hypertonicity of 690 mOsm/kg H20
using NaC1 did not further reduce ANP-stimulated cGMP generation in
IMCD, Hypertonicity using urea also inhibited ANP-stimulated guany-
late cyclase activity and cGMP generation in IMCD. On the other hand,
hypertonicity using NaCl stimulated AVP-stimulated cAMP generation
in IMCD, while hypertonicity using urea reduced it. In glomeruli,
hyperosmolality of 490 mOsmlkg . H20 using NaCI also reduced ANP-
stimulated cGMP generation, and hypertonicity of 690 mOsmlkg .H,O
using NaC1 further reduced it. In summary, hyperosmolality using NaC1
and urea inhibited ANP-sensitive guanylate cyclase activity and cGMP
generation both in IMCD and glomeruli. However, the mechanisms at
work may be different between NaCI and urea.
Atrial natriuretic peptide (ANP) is secreted from atrial myo-
cytes and is known to cause natriuresis and diuresis [1—6]. Its
physiological action is mediated by particulate guanylate cyclase-
coupled guanosine 3',5'-cyclic monophosphate (cGMP) synthe-
sis [7—10]. ANP stimulates cGMP generation in various portions
of the nephron [11—14]. ANP-stimulated cGMP generation was
highest in the inner medullary collecting duct (IMCD) among
nephron segments [13], suggesting that IMCD is one of the
major target sites for atrial natriuretic peptide. ANP causes
many physiological effects in IMCD. ANP inhibited ouabain-
sensitive oxygen consumption, which is closely related to
Na-K-ATPase activity, in rabbit IMCD cells [15]. ANP inhib-
ited sodium reabsorption in IMCD and 22Na uptake in IMCD
cells [16—20]. ANP also reduced medullary solute gradients,
which plays a key role in urine concentration [21]. ANP has also
been reported to inhibit vasopressin-stimulated osmotic water
permeability and a cation channel in IMCD [22, 23]. These data
suggest that ANP causes natriuresis and diuresis by inhibiting
sodium and water reabsorption in IMCD.
IMCD is the terminal segment of the nephron and is impor-
tant for urine concentration. The osmolality of interstitium
increases along the cortico-medullary axis. A hypertonic inter-
stitium of the renal medulla plays a key role in urine concen-
tration. Hypertonicity of medullary interstitium is generated by
the countercurrent multiplication system. Then, osmotic equil-
ibration of tubule fluid in IMCD with a hypertonic interstitium
occurs, making concentrated urine. Arginine vasopressin
(AVP), a key hormone for urine concentration, increases os-
motic water permeability and urea permeability in IMCD by
stimulating cAMP generation [24, 25]. Hypertonicity is known
to stimulate AVP action by increasing AVP-induced cAMP
generation in IMCD [24]. Hypertonicity caused by NaCl is
known to reduce ANP-sensitive particulate guanylate cyclase
activity in rabbit IMCD cells [261. This suggests that ANP-
stimulated cGMP generation may be reduced in a hypertonic
condition. However, the activity of guanylate cyclase was
measured in the presence of enough substrates, and many in
vivo factors affect the enzyme activity. Therefore, it is still
unknown whether hyperosmolality influences ANP-stimulated
cGMP generation and the diuretic and natnuretic action of ANP
in IMCD.
To learn whether hypertonicity influences the diuretic and
natriuretic action of ANP in IMCD, we investigated the effects
of hyperosmolality on ANP-stimulated cGMP generation and
guanylate cyclase in microdissected IMCDs of rats. Effect of
hyperosmolality on ANP-sensitive cGMP generation was also
examined in glomeruli, which is another major target site of
ANP, to learn whether hyperosmolar effect was specific for
IMCD, or whether it was a general feature for ANP-sensitive
guanylate cyclase system.
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Synthetic rat ANP of the 28-amino-acid peptide (ANP1_28)
was purchased from Peptide Institute (Osaka, Japan). AVP and
3-isobutyl-1-methylxanthine (IBMX) were obtained from Sigma
Chemical (St. Louis, Missouri, USA). Other chemicals were of
first grade.
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Experimental procedures
Male Sprague-Dawley rats weighing 70 to 90 g were killed by
decapitation. The left kidney was perfused with 10 ml of
ice-cold perfusion solution containing I mg/mi collagenase (type
I, 300 U/mg; Sigma Chemical) and 1 mg/mI bovine serum
albumin (BSA, fraction V). The perfusion solution contained
the following (in mM): 130 NaC1, 5 KC1, 1 NaH2PO4, 2
CH3COONa, 1 MgS0, 1 calcium lactate, 5.5 glucose, 5 L-ala-
nine, 2 L-leucine, 10 N-2-hydroxyethylpiperazine-N'-2-ethane-
sulfonic acid (HEPES), and pH was adjusted to 7.4 by adding
NaOH. Kidney slices were cut along a corticomedullary axis
and were incubated with the perfusion solution containing
collagenase and BSA for 40 minutes at 37°C under aeration with
100% 02. After incubation, the slices were washed four or five
times with the perfusion solution.
Microdissection of IMCD and glomeruli
Microdissection of IMCD and glomeruli was perfomed as
described previously [13, 14]. IMCDs were dissected from
whole inner medulla, since the collection of relatively long
IMCDs was required for the present experiment, and ANP-
stimulated cGMP accumulation was not different among IMCD
subsegments [14]. After microdissection, tubular length or
number of glomeruli was measured. The length of tubules used
for a single determination of cGMP content was 5 to 15 mm.
Segments of 1 mm length from IMCD were used for a single
determination of cAMP content. For a single determination of
guanylate cyclase activity, a 1- to 2-mm long IMCD was used.
Five to ten glomeruli were used for single determination of
cGMP content in glomeruli.
Measurement of cyclic nucleotide content
Measurements of cGMP and cAMP content were performed
as described previously [13, 14]. IMCDs or glomeruli were
transferred with 2 sl of the dissection solution containing 0.05%
BSA, using a siliconized glass pipette, into 1.5-mi plastic
centrifuge tubes containing 18 p1 of the dissection solution with
0.5 mM IBMX. The samples were pre-incubated for 10 minutes
at 37°C. Then, 20 p1 of isotonic or hypertonic solution with or
without ANP, AVP, or vehicle was added. Initially, the incu-
bation time was varied from 30 seconds to three minutes, to
learn the time course of the effect of hyperosmolality on ANP-
stimulated cGMP generation. To learn whether there was a
substrate depletion in our condition, 1 tM guanosine 5'-triphos-
phate (GTP) and 1 mrs adenosine 5'-tnphosphate (ATP) were
added in some experiments.
After those experiments, incubation time was fixed to three
minutes. After incubation for three minutes, the reaction was
stopped by adding 50 p1 of ice-cold 10% trichloroacetic acid
(TCA). Each tube was centrifuged for five minutes at 3,000 rpm
at 4°C, and 75 p1 of the supernatant was stored at —20°C until it
was assayed for cGMP or cAMP. In each experiment, blank
samples containing medium and TCA without tubules were also
taken for use as standards. The concentration of ANP was
varied from 10—8 to 106 M, to learn the dose-dependency of
ANP for hyperosmolality-induced inhibition of cGMP genera-
tion. In most of the experiments, 10—6 M ANP was used.
Hypertonic solution was made by adding NaCl or urea to
isotonic solution. Osmolality of isotonic solution was 290 to 300
mosm/kg . H20, and two kinds of hypertonic solution (490 and
690 m0sm/kg . H20) were made. We measured the osmolality
of the solution each time to make sure that the solution was
made correctly. The actual osmolality of isotonic and hyper-
tonic solutions using NaCl were 298 2,494 4, and 687 5
m0sm/kg H20, respectively. The osmolality of hypertonic
solution using urea was 495 5 m0sm/kg H20.
Frozen samples were thawed at room temperature, and TCA
was removed by extraction four times with 1 ml of water-
saturated ether. After evaporation of the ether, the remaining
aqueous phase was dried using a vacuum drying oven (Yamato
Scientific, Tokyo, Japan), and 100 p1 of 50 m sodium acetate
buffer (pH 6.2) were added to each sample. Appropriate con-
centrations of eGMP (0.5 to 500 fmol) or cAMP (ito 1,000 fmol)
standards in 50 m sodium acetate buffer were added to the
blank samples taken through the extraction procedure. Samples
of unknown and cGMP or cAMP standard were acetylated, and
then were assayed for cGMP or cAMP content using radioim-
munoassay kits (New England Nuclear, Boston, Massachu-
setts, USA). The standard curve of cGMP and cAMP assay for
hypertonic solution slightly shifted to the right compared with
that for isotonic solution. Therefore, a standard curve was
made differently for each osmolality.
Measurement of guanylate cyclase activity
Each microdissected IMCD was frozen in 2 p1 of the dissec-
tion solution containing 0.05% BSA until the assay. On the day
of the assay, the IMCD membrane was permeabilized by
freezing-and-thawing and sonication. Then, 18 pA of solution 2
were added. Solution 2 contained the following (in mM): 2 GTP,
10 MnCI2, 20 Hepes, and 1 IBMX. Next, we added 20 p1 of
NaCI solution with or without 2 x 1O_6 M ANP (final concen-
tration of 10_6 M), and the final osmolality of the incubation
solution was adjusted to 290 mOsm/kg . HO (using NaCI) or
490 m0sm/kg H0 (by further adding NaCL or urea). Each
sample was incubated for 5 or 10 minutes. After the incubation,
the reaction was stopped by adding 50 p1 of ice cold 10% TCA.
Each tube was centrifuged for five minutes at 3,000 rpm at 4°C,
and 75 p1 of supernatant was stored at —20°C until it was
assayed for cGMP. Blank samples containing medium and TCA
without IMCD were also stored for use as standards. The assay
of cGMP content was performed as described above.
Statistical evaluation
Statistical analysis was performed by using Student's t-test or
analysis of variance with multiple comparison by Dunnett's
method. A P < 0.05 was considered significant. Results are
expressed as means su.
Results
Effect of hypertonicity using NaCI on ANP-stimulated cGMP
generation in IMCD
Initially, the time course of the effect of hyperosmolality
using NaCl on ANP-stimulated cGMP generation in IMCD was
examined. A solution of 490 mOsm/kg . H0 (by adding NaC1)
and 10—6 M ANP was used in this experiment. The result
showed that hyperosmolality of 490 m0smlkg H20 inhibited
10—6 M ANP-induced cGMP generation as early as 30 seconds,
and this inhibition continued until three minutes (Fig. 1). Since
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Next, the concentration of ANP was varied from 10_8 to
M. The results showed the hyperosmolality-induced inhi-
bition of ANP-sensitive cGMP generation in IMCD at each
concentration of ANP (Fig. 3). Then, we varied the osmolality
from 490 to 690 mOsm/kg . H20 using NaC1. ANP-stimulated
cGMP generation was significantly reduced in all hypertonic
conditions compared with isotonic condition (1.35 0.14, 0.48
0.20, and 0.61 0.10 fmollmml3 mm, N = 5, in 290, 490, and
690 mOsmlkg ' H20 solution, respectively, Fig. 4). There was
no difference in ANP-stimulated cGMP generation between 490
and 690 mOsm/kg . HO. From these results, the hypertonic
condition of 490 mOsm/kg H20 was thought to be high enough
to reduce ANP-stimulated cGMP generation. Therefore, in the
following experiments, all of the hypertonic experiments were
done at 490 mOsmIkg H20 using 10_6 M ANP with the
1.5 2 2.5 3 incubation time of three minutes.
Time, minutes
Fig. 2. Time course of the effect of hvperosmolality on ANP-stimu-
lated cGMP generation in IMCD in the presence of 1 sM GTPand] mM
ATF. Although addition of GTP and ATP increased cGMP generation
three times, the time course of increase of ANP-dependent cGMP
generation and the inhibitory effect of hyperosmolality on it was not
changed. Symbols are (-G-) 290 mOsm; (--) 490 mOsm. < 0.05 and
< 0.01 vs. isotonic condition.
cGMP generation reached plateau at 30 seconds, it is possible to
speculate that the substrates depletion may occur. Therefore,
we conducted the experiment with same time course in the
presence of 1 sM GTP and 1 mrvt ATP. In this condition, cGMP
generation increased to 3 fmollmm, which is about three times
higher than in the absence of GTP and ATP (Fig. 2). However,
cGMP generation reached plateau at 30 seconds, and the
inhibitory effect of hyperosmolality was observed from 30
seconds to three minutes, just as it was in the absence of GTP
and ATP.
Effect of hypertonicily caused by urea on ANP-stimulated
cGMP generation in IMCD
Next, we compared the effect of hypertonicity made using
urea with the effect seen using NaC1. ANP-stimulated cGMP
generation was also reduced in hypertonic condition using urea
compared with isotonic condition (1.31 0.12, 0.68 0.11, and
0.71 0.04 fmollmml3 mm, N = 5, in 290 and 490 mOsm!
kg . H20 using NaC1, and 490 mOsmlkg H20 using urea,
respectively; Fig. 5).
Effect of hypertonicity on A VP-stimulated cAMP generation
in IMCD
Our data showed that hyperosmolality reduced ANP-sensi-
tive cGMP generation in IMCD. However, it is possible to
speculate that hypertonic solution damaged IMCD, and that
this damage caused low cGMP generation. To evaluate this
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Fig. 1. Time course of the effect of hyperosmolality on ANP-stimu-
lated cGMP generation in IMCD. Respective solutions of 290 (-0-) and
490 (-) mOsm/kg H20 (by adding NaCI) and 106 M ANP were
used. Hyperosmolality-induced inhibition of cGMP accumulation was
observed as early as 30 seconds after exposure to hypertonicity and it
continued until 3 minutes. *p < 0.05 and **p < 0.01 vs. isotonic
condition.
1.5
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Fig. 3. Effect of various concentrations of ANP on hyperosmolality-
induced inhibition of cGMP generation in IMCD. Symbols are (—0-) 290
mOsm; (-S-) 490 mOsm. 10_8 to 10_6 M ANP and incubation time of 3
minutes were used, Hyperosmolality of 490 mOsm/kg H0 was made
by adding NaCI to isotonic solution. < 0.05 vs. isotonic condition,
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Fig. 6. Effect of hyperosmolality on A VP-stimulated cAMP generation
in IMCD. In the hypertonic condition made using NaCI (central bar),
AVP-stimulated cAMP accumulation was significantly higher than in
the isotonic condition (left bar). On the other hand, cAMP accumulation
was slightly reduced in the hypertonic condition made using urea (right
bar). *P < 0.05, and ** < 0.01 vs. isotonic condition.
Effect of hypertonicity on ANP-stimulated cGMP generation
in glomerulus
possibility, we investigated the effect of the same hypertonic
condition on AVP-stimulated cAMP generation. In the hyper-
tonic condition made using NaC1, AVP-stimulated cAMP gen-
eration was significantly higher than in the isotonic condition
(270.4 26.0, and 471.5 6.9 fmollmml3 mm, N = 4, in 290
and 490 mOsm/kg . H20 using NaCI, respectively; Fig. 6). This
is compatible with previous reports [24]. The possibility of
damage of IMCD by high osmolality, namely by osmotic shock,
was unlikely in this experiment. On the other hand, cAMP
To learn whether hyperosmolality-induced inhibition of
ANP-stimulated cGMP generation is selective for the IMCD or
a general feature of ANP-induced guanylate cyclase activation,
we performed the same experiment in isolated glomeruli. Hy-
perosmolality of 490 and 690 mOsm/kg . H20were tested in the
presence of 108, i0, or 10—6 M ANP. Hyperosmolality of 490
mOsm/kg H20 decreased l0— and 10—6 M ANP-induced
cGMP generation, and hyperosmolality of 690 mOsm/kg HO
further decreased those (Fig. 9). These experiments showed
that hyperosmolality-induced inhibition of ANP-stimulated
600
400
200
0
290 490 (NaCI) 690 (NaCl)
E 1.5
C0
Osmolality mOsm/kg . H20
Fig. 4. Effect of hyperosmolalily by NaG! on ANP-stimulated cGMP
generation in IMCD. The osmolality of isotonic solution was 290
mOsm/kg . H20 (open bar), and that of hypertonic solution was 490 and
690 mOsm/kg H20 (closed bar). ANP-stimulated cGMP generation
was significantly reduced in the hypertonic condition compared with the
isotonic condition. There was no difference in ANP-stimulated cGMP
accumulation between 490 and 690 mOsm/kg H20. < 0.01 vs.
isotonic condition.
1.5
C0
0.5
a)0)
a-
C)
0
290 490 (NaCI) 490 (urea)
generation was slightly reduced in the hypertonic condition
made using urea.
Effect of hypertonicity on ANP-stimulated guanylate cyclase
activity in IMCD
To learn the mechanisms of hyperosmolality-induced inhibi-
tion of ANP-sensitive cGMP generation, we investigated the
effect of hypertonicity on ANP-stimulated guanylate cyclase
activity in IMCD. Hypertonicity made using both NaCl and
urea significantly reduced ANP-stimulated guanylate cyclase
activity in IMCD(7.7 1.1, 4.1 0.5, and 1.0 0.3, N = 4, in
290 and 490 mOsmlkg H20 using NaC1 and 490 mOsm!
kg H20 using urea, respectively; Fig. 7). Basal guanylate
cyclase activity was not changed by hyperosmolality.
490 (urea) Effect of AVP on ANP-stimulated cGMP generation in IMCD290 490 (NaCI)
OsmoaIity, mOsm/kg . H20
Fig. S. Effect of hyperosmolality using NaC1 or urea on ANP-stimu-
lated cGMP generation in IMCD. ANP-stimulated cGMP generation
was also reduced in the hypertonic condition using urea compared with
the isotonic condition (open bar). **p < 0.01 vs. isotonic condition.
We also examined the direct effect of AVP on ANP-stimu-
lated cGMP generation. In the presence of a high concentration
of AVP, the produced cAMP cross reacted with a small amount
of cGMP. After subtracting the cross reactivity, AVP did not
inhibit ANP-stimulated cGMP generation (Fig. 8).
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Fig. 7. Effect of hyperosmolality on ANP-stimulated guanylate cyclase
activity in IMCD. Hypertonicity made using both NaCI (•, 490 mOsm)
—Iog[ANPI
and urea (•, 490 mOsm) significantly reduced ANP-stimulated guany-
late cyclase activity in IMCD. Symbol (0) is 290 mOsm. *f1 < 0.05, and Fig. 9. Effect of hyperosmolality on ANP-stimulated cGMP generation
< 0.01 vs. isotonic condition. in glomerulus. Symbols are: (0) 290 mOsm; (•)490 mOsm; (•) 690
mOsm. Hypertonic solutions were made by adding NaCI to isotonic
solution. Hypertonic solution of 490 mOsm/kg . H20 reduced iO and
106 M ANP-dependent cGMP generation in glomeruli, and hypertonic
solution of 690 mOsm/kg . H20 further reduced it. *V < 0.05, <
0.01, and *** < 0.001 vs. isotonic condition.
E 0.75
in IMCD is suppressed in a hypertonic condition through
decreased guanylate cyclase activity. AVP itself did not show a
c 0.5 suppressive effect on ANP-induced cGMP accumulation in the
present study. The inhibitory effect of hyperosmolality on
ANP-stimulated cGMP generation was also observed in glomer-
uli, suggesting that this effect is a general feature for ANP-
0) 0.25 sensitive guanylate cyclase system. Since the changes of un-
nary and interstitial osmolality are small in cortex and very
large in inner medulla, this inhibitory effect of hyperosmolality
0 has an important physiological role in urine concentration in
inner medulla. ANP is a diuretic and natriuretic peptide, so this
adaptive change should be favorable to keep body fluid in an
antidiuretic condition.
Maximal osmolality of urine is about 1200 and 2000 mOsm!
kg . H20 in man and rat, respectively. Hyperosmolality-in-
duced inhibition of ANP-sensitive cGMP generation was ob-
served at an osmolality of 490 mOsmlkg H20, which is the
usual osmolality of urine. Furthermore, this inhibition was seen
as early as 30 seconds after the exposure to hypertonicity.
These data suggest that hyperosmolality quickly controls ANP
action in IMCD.
There are two types of ANP receptors: biologically active
and silent (clearance) receptors [27, 28]. Biologically-active
ANP receptors are classified into two iso-receptors: guanylate
cyclase-coupled ANP receptors A and B. Membrane-bound
guanylate cyclase itself is an ANP receptor, and cGMP is
considered to be a second messenger for ANP [7—9, 22]. ANP
has been demonstrated to increase particulate guanylate cy-
clase activity and cGMP generation markedly in glomeruli and
inner medullary collecting ducts [7, 8, 13]. Glomeruli have both
silent and biologically active ANP receptors, whereas IMCDs
have only biologically active receptors [11, 28, 29]. Gunning et
al reported a suppressive effect of hyperosmolality on ANP-
stimulated particulate guanylate cyclase activity in IMCD cells
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Fig. 8. Effect of AVP on ANP-stimulated cGMP generation in IMCD.
AVP did not directly inhibit ANP-stimulated cGMP generation.
cGMP generation is not selective for IMCD, but is a general
feature of guanylate cyclase.
However, the change of urine and interstitial osmolality is not
large in cortex and very large in inner medulla, suggesting the
physiological importance of the inhibitory effect of hyperosmo-
lality mainly in inner medulla.
Discussion
The main role of the kidney is to maintain body fluid
homeostasis by concentrating or diluting urine. Medullary
hyperosmolality in interstitium plays a key role in urine con-
centration. The thin descending, ascending and thick ascending
limbs of Henle's loop, collecting ducts, and vasa recta partici-
pate in the renal countercurrent multiplication system to make
a hypertonic interstitium. A hyperosmotic condition is known
to enhance the antidiuretic action of AVP in IMCD. The present
study demonstrated that ANP-stimulated cGMP accumulation
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[26]. They used NaC1 and urea to increase the osmolality. Their
study showed a significant inhibition of particulate guanylate
cyclase activity by NaC1, but not by urea, which differs slightly
from our results. They explained the difference between NaCl
and urea by saying that the inhibitory effect was not a response
to osmolality per Se, but more likely a response to increased
local NaCI concentration. The difference between the experi-
mental results of Gunning and colleagues and ours may be
attributable to the different animals used: they used rabbit
IMCDs and we used rat IMCDs. There are many differences
between rabbits and rats. For example, pH of urine is usually
alkaline in rabbits and acidic in rats. Therefore, there may be
such differences between the experimental results of Gunning et
al and our own.
Although our results show that hyperosmolality caused by
both NaC1 and urea inhibited ANP-stimulated cGMP generation
and guanylate cyclase activity, NaCI and urea showed different
effects on AVP-stimulated cAMP generation. Urea inhibited
both ANP-stimulated cGMP generation and AVP-stimulated
cAMP generation. This suggests the possibility that a high urea
concentration, rather than high osmolality, may have inhibited
both cyclic nucleotide accumulations by inhibiting metabolic
processes. The effect of NaCI on the action of AVP and ANP is
quite reasonable. NaCI enhances the antidiuretic action of
AVP, whereas it reduces the natriuretic action of ANP in
IMCD. This adaptative response would be important in such
physiological and pathological states as dehydration, where salt
and water retention is required. In dehydration, the concentra-
tions of urea and NaC1 and osmolality in inner medullary
interstitium increase. Therefore, the natiuretic and diuretic
effect of ANP are suppressed by a high concentration of urea
and/or NaCI, and/or high osmolality.
NaCl inhibited both ANP-dependent guanylate cyclase and
cGMP generation in the present study. Gunning et al reported
that NaC1 inhibited ANP-dependent particulate guanylate cy-
clase in concentrations of substrate at the Km (0.55 mrvi Mn2-
GTP), but not in the Vmax (5 mri Mn2-GTP) of the enzyme
[26]. We used 0.9 ms GTP and 4.5 mss MnCl2 for the assay of
guanylate cyclase. We measured total, but not particulate
guanylate cyclase, using microdissected IMCDs. Since ANP is
known to stimulate particulate, but not soluble guanylate cy-
clase, and since NaCl and urea did not inhibit basal guanylate
cyclase activity in the present study, the inhibitory effect of
NaCl and urea on guanylate cyclase is probably mainly through
the inhibition of particulate guanylate cyclase.
An inhibitory effect of hyperosmolality on ANP-stimulated
cGMP generation was observed not only in IMCD, but also in
glomeruli. This result suggests that the inhibitory effect of
hyperosmolality on ANP-sensitive cGMP generation is not
selective for IMCD, but is a general feature of ANP-sensitive
guanylate cyclase system. However, the osmolalty of intersti-
tium increases along the cortico-medullary axis. Osmolalities of
interstitium and urine in inner medulla increase to 1,200 or 2,000
mOsm/kg• H20 in dehydration in human and rats, respec-
tively, whereas those in cortex are relatively stable. Therefore,
hyperosmolality-induced inhibition of ANP-sensitive cGMP
generation plays an important role in IMCD, but not in glomer-
ulus.
ANP-dependent cGMP generation depends on several steps,
such as binding of ANP to its receptors, guanylate cyclase
activity, phosphodiesterase activity, and substrate availability.
Both Gunning et al and we have shown that hyperosmolality
(NaCl) reduces ANP-sensitive guanylate cyclase activity. We
have not examined whether hyperosmolality influences the
binding of ANP to its receptors. There is a possibility that
hypertonicity inhibits binding of ANP to its receptors. This
could be the reason for hyperosmolality-induced inhibition of
ANP-sensitive cGMP generation in glomeruli and IMCD. Since
our experiments were done in the presence of IBMX, a phos-
phodiesterase inhibitor, the participation of phosphodiesterase
in hyperosmolality-induced inhibition of ANP-dependent
cGMP generation should be small. In the presence of 1 jLMGTP
and 1 mM ATP, ANP-dependent cGMP generation was three
times higher than without GTP and ATP, suggesting that such
substrates may not be sufficient in physiological, or at least our
experimental conditions. However, time course of increase of
ANP-dependent cGMP generation was not changed. Further-
more, time course of hyperosmolality-induced inhibition of
ANP-sensitive cGMP generation was not changed in the pres-
ence of GTP and ATP. Thus, substrate availability may not be
an important factor for hyperosmolality-induced inhibition of
ANP-dependent cGMP generation. Further investigations are
necessary to elucidate the mechanisms of hyperosmolality-
induced inhibition of ANP-sensitive cGMP generation.
Cell volume regulation has important roles in the cell function
of IMCD. A sudden increase in extracellular osmolality causes
cell shrinkage due to efflux of water, but then a volume
regulatory increase of cell volume occurs. The volume regula-
tory increase has two steps: short-term regulation by ion
transport, and long-term regulation by accumulation of organic
osmolytes [30—32]. Hyperosmolality caused by NaC1 inhibited
ANP-dependent cGMP generation at 30 seconds in the present
study. This effect is quite acute. It takes several hours, at least,
for the accumulation of organic osmolytes in inner medulla [33].
Therefore, a participation of organic osmolytes in the high-
osmolality-induced inhibition of ANP-stimulated cGMP gener-
ation is unlikely. NaC1 transport probably plays a key role in
this acute adaptive change. The accumulation of organic os-
molytes in IMCD may counteract hyperosmolality-induced
acute inhibition of ANP-stimulated cGMP generation. Possibil-
ities of other unknown mechanisms still remain [34, 35].
In summary, acute exposure to hyperosmolality caused by
NaCI and urea inhibited ANP-dependent cGMP generation in
IMCD and glomeruli. This adaptive change should be favorable
for the kidney, especially for the renal medulla, to maintain
body fluid homeostasis in antidiuretic condition. The findings
that the effects of NaCI and urea on AVP-stimulated cAMP
generation in IMCD are different suggest the possibility that the
mechanisms of NaCl and urea may be different. Ion transport
(mainly NaCI) rather than hyperosmolality may play a key role
in this adaptation. Further experiments are needed to determine
whether ion transport, or hyperosmolality itself, induces this
adaptation, and also determine whether long-term exposure to
hyperosmolality, which will induce the accumulation of organic
osmolytes in the cell, influences this adaptive change.
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